Literature DB >> 22150275

Diversity of integrase-hydrolyzing IgGs and IgMs from sera of HIV-infected patients.

S V Baranova1, V N Buneva, M A Kharitonova, L P Sizyakina, O D Zakharova, G A Nevinsky.   

Abstract

It was previously shown that small fractions of IgGs and IgMs from the sera of AIDS patients specifically hydrolyze only HIV integrase (IN) but not many other tested proteins. Here we present evidence showing that these IgGs and IgMs are extreme catalytically heterogeneous. Affinity chromatography on IN-Sepharose using elution of IgGs (or IgMs) with different concentration of NaCl and acidic buffer separated catalytic antibodies (ABs) into many AB subfractions demonstrating different values of K(m) for IN and k(cat). Nonfractionated IgGs and IgMs possess serine-, thiol-, acidic-like, and metal-dependent proteolytic activity. Metal-dependent activity of abzymes increases in the presence of ions of different metals. In contrast to canonical proteases having one pH optimum, initial nonfractionated IgGs and IgMs demonstrate several optima at pH from 3 to 10. The data obtained show that IN-hydrolyzing polyclonal IgG and IgM of HIV-infected patients are cocktails of anti-IN ABs with different structure of the active centers possessing various affinity to IN, pH optima, and relative rates of the specific substrate hydrolysis. © Pleiades Publishing, Ltd., 2011.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22150275     DOI: 10.1134/S0006297911120030

Source DB:  PubMed          Journal:  Biochemistry (Mosc)        ISSN: 0006-2979            Impact factor:   2.487


  2 in total

Review 1.  Antibody-Mediated Catalysis in Infection and Immunity.

Authors:  Anthony Bowen; Maggie Wear; Arturo Casadevall
Journal:  Infect Immun       Date:  2017-08-18       Impact factor: 3.441

2.  Association of pol diversity with antiretroviral treatment outcomes among HIV-infected African children.

Authors:  Iris Chen; Leila Khaki; Jane C Lindsey; Carrie Fry; Matthew M Cousins; Robert F Siliciano; Avy Violari; Paul Palumbo; Susan H Eshleman
Journal:  PLoS One       Date:  2013-11-27       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.